JP2022505144A5 - - Google Patents

Info

Publication number
JP2022505144A5
JP2022505144A5 JP2021521063A JP2021521063A JP2022505144A5 JP 2022505144 A5 JP2022505144 A5 JP 2022505144A5 JP 2021521063 A JP2021521063 A JP 2021521063A JP 2021521063 A JP2021521063 A JP 2021521063A JP 2022505144 A5 JP2022505144 A5 JP 2022505144A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antigen
antibody variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021521063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022505144A (ja
JP7625516B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/043179 external-priority patent/WO2020095866A1/en
Publication of JP2022505144A publication Critical patent/JP2022505144A/ja
Publication of JP2022505144A5 publication Critical patent/JP2022505144A5/ja
Application granted granted Critical
Publication of JP7625516B2 publication Critical patent/JP7625516B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021521063A 2018-11-05 2019-11-05 Ｈｅｒ２ ｓ３１０ｆ特異的な抗原結合分子 Active JP7625516B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018207927 2018-11-05
JP2018207927 2018-11-05
PCT/JP2019/043179 WO2020095866A1 (en) 2018-11-05 2019-11-05 Her2 s310f specific antigen-binding molecules

Publications (3)

Publication Number Publication Date
JP2022505144A JP2022505144A (ja) 2022-01-14
JP2022505144A5 true JP2022505144A5 (https=) 2022-10-27
JP7625516B2 JP7625516B2 (ja) 2025-02-03

Family

ID=70611778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521063A Active JP7625516B2 (ja) 2018-11-05 2019-11-05 Ｈｅｒ２ ｓ３１０ｆ特異的な抗原結合分子

Country Status (4)

Country Link
US (1) US20220033516A1 (https=)
EP (1) EP3877420A4 (https=)
JP (1) JP7625516B2 (https=)
WO (1) WO2020095866A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3434767T (pt) 2010-11-30 2026-01-23 Chugai Pharmaceutical Co Ltd Agente terapêutico indutor de citotoxicidade
CN116601173A (zh) * 2020-09-11 2023-08-15 阿雷克森制药公司 抗铜蓝蛋白抗体及其用途
CN115327134B (zh) * 2022-08-26 2025-03-18 复旦大学附属中山医院 Erbb2 s310f突变的抗体在制备诊断检测胆囊癌中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
AU2012245116A1 (en) * 2011-04-20 2013-11-07 Genmab A/S Bispecific antibodies against HER2 and CD3
US8697676B2 (en) * 2011-06-15 2014-04-15 Ronald E Rosedale Omega-3 fatty acid nutriceutical composition and optimization method
IL263466B2 (en) * 2013-12-17 2023-10-01 Genentech Inc Anti-CD3 antibodies and methods of using them

Similar Documents

Publication Publication Date Title
US20210024635A1 (en) Anti-wt1/hla-specific antibodies
TWI805121B (zh) 抗ＳＩＲＰα抗體及其用途
JP7257971B2 (ja) 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用
CN110382536A (zh) 抗pd-1抗体及其用途
TW201026325A (en) Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
JP2022533538A5 (https=)
JP7728595B2 (ja) 二重特異性抗体及びその用途
CN112243443B (zh) 抗trop-2抗体、其抗原结合片段及其医药用途
JP2022505144A5 (https=)
JP2026508246A (ja) 抗体、抗原結合フラグメント及び使用方法
WO2022179466A1 (zh) 抗Siglec15抗体及其用途
CN113135995A (zh) 抗her3单克隆抗体及其应用
US20250066499A1 (en) Antibody binding to human cd73, preparation method therefor, and use thereof
CN112805297B (zh) 抗人类pd-l1抗体及其用途
JP2025537255A (ja) 抗アルファ５インテグリン抗体及びその使用
US20220387417A1 (en) Pharmaceutical Combination and Use Thereof
US20170183401A1 (en) Hypoglycemic agent containing anti-ang2 antibody
TWI889920B (zh) 抗ｔｒｏｐ-２抗體、其抗原結合片段或其突變體、及其醫藥用途
WO2025245264A1 (en) Anti-b7-h3 antibodies and methods of use thereof
WO2026010986A1 (en) 5t4-binding proteins
TW202432593A (zh) 抗體、其抗原結合片段及其藥物用途
TW202540198A (zh) 雙特異性抗體樣蛋白以及彼之製造及使用方法
WO2026017120A1 (zh) 抗cdh17/egfr/cd16a三特异性抗体及其用途
WO2024245388A1 (zh) 抗pvrig抗体及其应用
CN117503951A (zh) 一种抗体药物偶联物及其医药用途